caa a22 4500 605490732 CHVBK 20210128100506.0 cr unu---uuuuu 210128e20151201xx s 000 0 eng 10.1007/s10147-015-0845-0 doi (NATIONALLICENCE)springer-10.1007/s10147-015-0845-0 Psychological impact of breast cancer screening in Japan [Elektronische Daten] [Atsuko Kitano, Hideko Yamauchi, Takashi Hosaka, Hiroshi Yagata, Keiko Hosokawa, Sachiko Ohde, Seigo Nakamura, Masafumi Takimoto, Hiroko Tsunoda] Objective: The purpose of this study was to evaluate the psychological impact of breast cancer screening by use of mammography and/or ultrasound, and to reveal factors related to psychological distress. Methods: Three hundred and twenty women were recalled to our hospital because of suspicious malignant findings from breast cancer screening between March and November 2012. They were asked to complete three questionnaires: the Hospital Anxiety and Depression Scale (HADS) for anxiety and depression, the Brief Coping Orientations to Problems Experienced scale (Brief COPE) for coping styles, and an original questionnaire for personal information. Results: Complete data were available for 312 of 320 women (97.5%). The median age was 45years (range 23-73). The HADS revealed borderline or clinically significant anxiety for 70% of the women. Family history of breast cancer, area of residence, number of times screened, number of recalls, and the period before the first visit were significantly related to psychological distress (p<0.05). Brief COPE scores showed that self-blame, behavioral disengagement, self-distraction, use of emotional support, venting, denial, and less acceptance were related to increased anxiety. Conclusion: Seventy percent of women who were recalled after breast cancer screening experienced psychological distress. Thus, negative psychological impact should be regarded as an adverse effect of breast cancer screening. Japan Society of Clinical Oncology, 2015 Psychological distress nationallicence Breast screening nationallicence Breast cancer nationallicence Psychological impact nationallicence Kitano Atsuko Department of Medical Oncology, St. Luke's International Hospital, Tokyo, Japan aut Yamauchi Hideko Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan aut Hosaka Takashi Department of Psycho-oncology, St. Luke's International Hospital, Tokyo, Japan aut Yagata Hiroshi Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan aut Hosokawa Keiko Department of Nursing, St. Luke's International Hospital, Tokyo, Japan aut Ohde Sachiko Center of Clinical Epidemiology, St. Luke's Life Science Institute, Tokyo, Japan aut Nakamura Seigo Department of Breast Surgical Oncology, Showa University School of Medicine, Tokyo, Japan aut Takimoto Masafumi Department of Pathology and Laboratory Medicine, Showa University of School of Medicine, Tokyo, Japan aut Tsunoda Hiroko Department of Radiology, St. Luke's International Hospital, 9-1 Akashi-cho Chuo-ku, 104-8560, Tokyo, Japan aut International Journal of Clinical Oncology Springer Japan 20/6(2015-12-01), 1110-1116 1341-9625 20:6<1110 2015 20 10147 https://doi.org/10.1007/s10147-015-0845-0 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10147-015-0845-0 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Kitano Atsuko Department of Medical Oncology, St. Luke's International Hospital, Tokyo, Japan aut NATIONALLICENCE 700 1- Yamauchi Hideko Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan aut NATIONALLICENCE 700 1- Hosaka Takashi Department of Psycho-oncology, St. Luke's International Hospital, Tokyo, Japan aut NATIONALLICENCE 700 1- Yagata Hiroshi Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan aut NATIONALLICENCE 700 1- Hosokawa Keiko Department of Nursing, St. Luke's International Hospital, Tokyo, Japan aut NATIONALLICENCE 700 1- Ohde Sachiko Center of Clinical Epidemiology, St. Luke's Life Science Institute, Tokyo, Japan aut NATIONALLICENCE 700 1- Nakamura Seigo Department of Breast Surgical Oncology, Showa University School of Medicine, Tokyo, Japan aut NATIONALLICENCE 700 1- Takimoto Masafumi Department of Pathology and Laboratory Medicine, Showa University of School of Medicine, Tokyo, Japan aut NATIONALLICENCE 700 1- Tsunoda Hiroko Department of Radiology, St. Luke's International Hospital, 9-1 Akashi-cho Chuo-ku, 104-8560, Tokyo, Japan aut NATIONALLICENCE 773 0- International Journal of Clinical Oncology Springer Japan 20/6(2015-12-01), 1110-1116 1341-9625 20:6<1110 2015 20 10147